Eye on AI: Applying Artificial Intelligence to Drive Cancer Research, Part 1
Researchers highlighted AI's potential to enhance cancer research, including to discover cancer drivers and new therapeutic opportunities.
Progress Against Cancer
Researchers highlighted AI's potential to enhance cancer research, including to discover cancer drivers and new therapeutic opportunities.
Doctors often don’t discuss sexual side effects with breast cancer survivors, and cardiac biomarkers may indicate increased risk for certain cancers.
Researchers are exploring which cancer types have higher incidence in people under 50, what may be causing this rise of early-onset cancers.
This month, the AACR's journals editors highlighted studies on U.S. cancer mortality hotspots, chemotherapy-induced hearing loss, and more.
Advances in cardio-oncology are redefining cancer care, shaping safer treatments to protecting patients’ hearts.
This post examines ultraprocessed foods and what current research shows about how they impact health and cancer risk.
Steroids at the start of immunotherapy can negatively affect response, and colorectal cancer may lead to sexual side effects in women.
New AI-driven models unveiled at the AACR Annual Meeting 2025 could revolutionize how we diagnose sarcomas in children.
Study found teclistamab-cqyv, an immunotherapy, led to responses in patients with high-risk, heavily pretreated multiple myeloma, including after prior BCMA therapy. Teclistamab-cqyv (Tecvayli), a type of immunotherapy, received accelerated approval from the U.S. Food...
‘Practice-changing’ research shows adding immunotherapy before and after surgery reduced recurrences for early-stage gastric cancer.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More